Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Advanced Melanoma
NCT01136967Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of lenvatinib in melanoma, sponsored by Eisai Co., Ltd.. Started Aug 2010; status: completed.
02
Drugs
lenvatinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01136967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01136967.